Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_session6jrn1sf5c4esma8cte1tfs7rn0l7sluk): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Background: Rheumatic heart disease constitutes a significant disease burden in under-resourced communities. Recognition of the devastating impact of rheumatic heart disease has resulted in volunteer cardiac teams from Australasia providing surgical services to regions of need. The primary objective of this study was to compare New Zealand hospitals' volunteer cardiac surgical operative results in Samoa and Fiji with the accepted surgical mortality and morbidity rates for Australasia.
Methods: A retrospective review from seven volunteer cardiac surgical trips to Samoa and Fiji from 2003 to 2009 was conducted. Patient data were retrospectively and prospectively collected. Preoperative morbidity and mortality risk were calculated using the European System for Cardiac Operative Risk Evaluation (euroSCORE). Audit data were collated in line with the Australasian Society of Cardiac and Thoracic Surgeons guidelines.
Results: One hundred and three operations were performed over 6 years. EuroSCORE predicted an operative mortality of 3.32%. In-hospital mortality was 0.97% and post-discharge mortality was 2.91%, resulting in a 30-day mortality of 3.88%.
Conclusion: This study demonstrated that performing cardiac surgery in Fiji and Samoa is viable and safe. However, the mortality was slightly higher than predicted by euroSCORE. Difficulties exist in predicting mortality rates in patients with rheumatic heart disease from Pacific Island nations as known risk scoring models fail to be disease, ethnically or culturally inclusive. Audit processes and risk model development and assessment are an essential part of this complex surgical charity work and will result in improved patient selection and outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1445-2197.2011.05899.x | DOI Listing |
J Assoc Physicians India
March 2025
Associate, Department of Medicine, LN Medical College and JK Hospital, Bhopal, Madhya Pradesh, India.
This case report describes a unique occurrence of rheumatic heart disease (RHD) with severe mitral, tricuspid, and pulmonary stenosis in a 17-year-old female. The patient presented with progressive exertional dyspnea and dependent edema. She had a history of acute rheumatic fever and joint pain 5 years ago.
View Article and Find Full Text PDFSemin Arthritis Rheum
February 2025
Director, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Canada; Professor, School of Epidemiology and Public Health, University of Ottawa, Canada; Professor, Department of Medicine, University of Ottawa, Canada.
Background: Literature reviews of measurement properties of an outcome measurement instrument are fast becoming the evidence base for making decisions about the suitability of the instrument for a given application. In our case at OMERACT it is the fitness of an instrument for inclusion in a Core Outcome Set. Transparency in the processes and decision making at each step are important to allow consumers of the literature review to have a clear understanding of the decision-making process.
View Article and Find Full Text PDFJ Thorac Dis
February 2025
Department of Cardiac Surgery Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Background: Currently, mitral valve replacement is the primary method of reintervention for patients with rheumatic heart disease (RHD) after percutaneous mitral balloon commissurotomy (PMBC). This study aims to investigate the feasibility of mitral valve repair in such patients and report its therapeutic outcomes compared to mitral valve replacement.
Methods: Data from patients with previous PMBC who underwent mitral valve surgery as disease progression between January 2011 and August 2023 were retrospectively analyzed.
Biomed Mater
March 2025
The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuanjiagang Street, Yuzhong District, Chongqing, China, Chongqing, Chongqing, 400016, CHINA.
Curcumin is a natural polyphenol extracted from plants that interacts with various molecular targets and exhibits antioxidant, antibacterial, anticancer, and anti-aging properties. Due to its various pharmacological activities and high safety margin, curcumin has been used in the prevention and treatment of various diseases, including Alzheimer's, heart, and rheumatic immune diseases. To develop curcumin eye drops that can be used as antioxidant and antibacterial agents after phacoemulsification, we designed a nano-based drug delivery system to improve curcumin bioavailability and duration of action.
View Article and Find Full Text PDFBMJ Open
March 2025
Zora Biosciences Oy, Espoo, Finland
Objectives: This study aimed to explore the association between lipid-based Cardiovascular Event Risk Tests (CERT1 and CERT2), including ceramides (Cer) and phosphatidylcholine (PC) lipid species, and rheumatoid arthritis (RA), an inflammatory disease that can increase the risk of cardiovascular diseases.
Design: Prospective population-based cohort study.
Setting: Primary care centres across five geographical areas in Finland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!